Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion

Spine

Volumn 21, Issue 18, 1996, Pages 2115-2122

  Sandhu, Harvinder S ^a   Kanim, Linda E A ^a   Kabo, J Michael ^a   Toth, Jeffrey M ^b   Zeegen, Erik N ^a   Liu, David ^a   Delamarter, Rick B ^a   Dawson, Edgar G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

bone induction; bone morphogenetic protein; dog; polylactic acid polymer; posterolateral fusion; recombinant human bone morphogenetic protein 2

Indexed keywords

BONE MORPHOGENETIC PROTEIN; POLYLACTIC ACID; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SPINE FUSION; SPINE RADIOGRAPHY; SURGICAL TECHNIQUE;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CROSS-SECTIONAL STUDIES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FEMALE; LACTIC ACID; LUMBAR VERTEBRAE; OSTEOGENESIS; POLYMERS; RECOMBINANT PROTEINS; SPINAL FUSION; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029740478     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-199609150-00012     Document Type: Article

References (25)

1. Aldinger G, Herr G, Kusswetter W, Reis HJ, Thielemann FW, Holz U. Bone morphogenetic protein: A review. Int Orthop (SICOT) 1991;15:169-77.
2. Aspenberg P, Wang E, Thorngren KG. Bone morphogenetic protein induces bone in the squirrel monkey, but bone matrix does not. Proc Orthop Res Soc 1993;39:101.
3. Bostrom MPG, Tomin E, Lane JM, et al. The use of recombinant bone morphogenetic protein (rhBMP-2) in the rabbit ulnar non-union model: a radiographic, biomechanical and histological dose response study. Clin Orthop; in press.
4. Callewart CC, Kanim LEA, Seeger LL, Dawson EG. Variable fusion rates in the canine model. Presented at the 29th Annual Meeting of the Scoliosis Research Society, Portland, Oregon, September 23, 1994.
5. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud III TS. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg [Am] 1994; 76:827-38.
6. Cook SD, Dalton JE, Tan EH, Whitecloud III TS, Rueger DC. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 1994;19:1655-63.
7. Ferguson D, Davis WL, Urist MR, Hurt WC, Allen EP. Bovine bone morphogenetic protein (bBMP) fraction-induced repair of craniotomy defects in the rhesus monkey (Macaca speciosa). Clin Orthop 1987;219:251-6.
8. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 1993;293:317-26.
9. Lee SC, Shea M, Battle MA, et al. Healing of large segmentai defects in rat femurs is enhanced by rhBMP-2 in a PLGA matrix: A torsional and densitometric assessment. Proc Orthop Res Soc 1994;40:206.
10. Lucas PA, Syftestad GT, Goldberg VM, Caplan AI. Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a collagenous delivery vehicle. J Biomed Mater Res 1989;23:23-39.
11. Luyten FP, Cunningham NS, Vukicevic S, Paralkar V, Ripamonti U, Reddi AH. Advances in osteogenin and related bone morphogenetic proteins in bone induction and repair. Acta Orthop Belg 1992;58(Suppl 1):263-8.
12. Lyons KM, Pelton RW, Hogan BLM. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. Genes Dev 1989; 3:1657-68.
13. Miyamoto S, Takaoka K, Okada T, et al. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin Orthop 1992;278:274-86.
14. Saitoh H, Takata T, Nikai H, Shintani H, Hyon SH, Ikada Y. Effect of polylactic acid on osteoinduction of demineralized bone: Preliminary study of the usefulness of polylactic acid as a carrier of bone morphogenetic protein. J Oral Rehabil 1994;21:431-8.
15. Sandhu HS. UCLA School of Medicine, Los Angeles, California (unpublished data).
16. Sandhu HS, Kanim LEA, Kabo JM, et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 1995;20: 2669-82.
17. Simmons DJ, Calhoun JH, Zimmerman B, Brantley J, Mader JT. Effect of recombinant human bone morphogenetic protein (rhBMP-2) on the healing of cortical bone in the rabbit tibia. Proc Orthop Res Soc 1994;40:507.
18. Urist MR. The search for and discovery of bone morphogenetic protein (BMP). In: Urist MR, O'Conner BT, Burwell RG, eds. Bone Grafts, Derivatives and Substitutes. London: Butterworth Heinemann, 1994:315-62.
19. Urist MR, Huo YK, Brownell AG, et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci U S A 1984;81: 371-5.
20. Urist MR, Lietze A, Dawson EG, Finerman GAM. Bone morphogenetic protein (BMP) delivery system. Presented at the 11 th Annual Meeting of the Society for Biomaterials, San Diego, California, April 25-28, 1985.
21. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A 1979;76:1828-32.
22. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A 1988;85:9484-8.
23. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Nat Acad Sci U S A 1990;87:2220-4.
24. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992;32:160-7.
25. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg [Am] 1992;74:659-70.